loading

Finanzdaten der Tyra Biosciences Inc-Aktie (TYRA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
12.92%
22.32
25.63 23.96 16.01 14.33
Operating Income/Loss
12.92%
-22.32
-25.63 -23.96 -16.01 -14.33
Nonoperating Income/Loss
47.29%
4.13
2.804 2.811 2.742 2.454
Income/Loss From Continuing Operations Before Tax
20.32%
-18.19
-22.83 -21.15 -13.27 -11.88
Income/Loss From Continuing Operations After Tax
20.32%
-18.19
-22.83 -21.15 -13.27 -11.88
Net Income/Loss
20.32%
-18.19
-22.83 -21.15 -13.27 -11.88
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
60,772%
52.23
0.0858 42.87 42.59 42.39
Diluted Average Shares
60,772%
52.23
0.0858 42.87 42.59 42.39
Basic Earnings Per Share
33.96%
-0.35
-0.53 -0.49 -0.31 -0.28
Diluted Earnings Per Share
33.96%
-0.35
-0.53 -0.49 -0.31 -0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):